Design to come?
WP_Post Object ( [ID] => 1054 [post_author] => 3 [post_date] => 2021-11-30 11:49:47 [post_date_gmt] => 2021-11-30 16:49:47 [post_content] => [post_title] => Intensity Therapeutics Announces New Clinical Data Presentation for its Lead Asset, INT230-6, in Breast Cancer, at the 2021 San Antonio Breast Cancer Symposium® in December [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => intensity-therapeutics-announces-new-clinical-data-presentation-for-its-lead-asset-int230-6-in-breast-cancer-at-the-2021-san-antonio-breast-cancer-symposium-in-december [to_ping] => [pinged] => [post_modified] => 2021-11-30 11:49:47 [post_modified_gmt] => 2021-11-30 16:49:47 [post_content_filtered] => [post_parent] => 0 [guid] => https://vcapital.com/?post_type=news&p=1054 [menu_order] => 0 [post_type] => news [post_mime_type] => [comment_count] => 0 [filter] => raw )